Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.

Abstract:

:An estrogen receptor immunocytochemical assay which uses monoclonal antibodies to the estrogen receptor protein [Nature (Lond.), 307: 745-747, 1984] was applied to several human tissues, including human breast tumors, and the results were compared to those of steroid-binding assays performed on cytosol extracts of the same tissues. Specific immunoperoxidase staining in fixed, frozen sections was confined to the nucleus of selected cell populations within each tissue examined. In 117 human breast cancers, the presence or absence of nuclear staining was significantly associated with the concentration of cytosolic estrogen receptor. Thirty-eight estrogen receptor immunocytochemical assay-positive tumors were further assessed for several quantifiable features of the staining, including intensity, cellularity, and the proportion of tumor cells stained. Of these, epithelial cellularity showed the highest degree of correlation with the results of steroid-binding assays.

journal_name

Cancer Res

journal_title

Cancer research

authors

King WJ,DeSombre ER,Jensen EV,Greene GL

subject

Has Abstract

pub_date

1985-01-01 00:00:00

pages

293-304

issue

1

eissn

0008-5472

issn

1538-7445

journal_volume

45

pub_type

杂志文章
  • Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.

    abstract::We performed a phase I trial of cyclosporin A (CsA) in combination with doxorubicin (dox) to determine the maximally tolerated dose (MTD) of the combination in man, to define the quantitative and qualitative toxicities of the combination, and to determine the pharmacokinetics of the two drugs when used together. CsA w...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Erlichman C,Moore M,Thiessen JJ,Kerr IG,Walker S,Goodman P,Bjarnason G,DeAngelis C,Bunting P

    更新日期:1993-10-15 00:00:00

  • Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.

    abstract::Overexpression of ABCB1 (MDR1) P-glycoprotein, a multidrug efflux pump, is one mechanism by which tumor cells may develop multidrug resistance (MDR), preventing the successful chemotherapeutic treatment of cancer. Sesquiterpenes from Celastraceae family are natural compounds shown previously to reverse MDR in several ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1005

    authors: Muñoz-Martínez F,Lu P,Cortés-Selva F,Pérez-Victoria JM,Jiménez IA,Ravelo AG,Sharom FJ,Gamarro F,Castanys S

    更新日期:2004-10-01 00:00:00

  • Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.

    abstract::The antiapoptotic protein bcl-2 is found up-regulated in a number of malignant and premalignant skin conditions of keratinocyte origin, but in normal skin, it is expressed at low levels only in interfollicular epidermis. To investigate whether unregulated bcl-2 expression could affect the incidence of epidermal tumors...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rossiter H,Beissert S,Mayer C,Schön MP,Wienrich BG,Tschachler E,Kupper TS

    更新日期:2001-05-01 00:00:00

  • Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.

    abstract::The ability to induce pluripotent stem cells from committed, somatic human cells provides tremendous potential for regenerative medicine. However, there is a defined neoplastic potential inherent to such reprogramming that must be understood and may provide a model for understanding key events in tumorigenesis. Using ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1361

    authors: Ohm JE,Mali P,Van Neste L,Berman DM,Liang L,Pandiyan K,Briggs KJ,Zhang W,Argani P,Simons B,Yu W,Matsui W,Van Criekinge W,Rassool FV,Zambidis E,Schuebel KE,Cope L,Yen J,Mohammad HP,Cheng L,Baylin SB

    更新日期:2010-10-01 00:00:00

  • Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.

    abstract::Recent work on a variety of normal and malignant cell lines has shown that induction and secretion of biologically active TGF-beta may occur after exposure to all-trans-retinoic acid (RA), coincident with decreased growth rate and/or differentiation. This study evaluates the expression and regulation of transforming g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cohen PS,Letterio JJ,Gaetano C,Chan J,Matsumoto K,Sporn MB,Thiele CJ

    更新日期:1995-06-01 00:00:00

  • 3-Deazaguanine: inhibition of initiation of translation in L1210 cells.

    abstract::In L1210 cells in culture, 3-deazaguanine (DG), a relatively new purine analog, was found to inhibit DNA and protein synthesis but not total RNA synthesis. The effect of the drug on protein synthesis was therefore further examined. Polyadenylic acid-containing RNA synthesis was not decreased by DG treatment, suggestin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rivest RS,Irwin D,Mandel HG

    更新日期:1982-10-01 00:00:00

  • Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252.

    abstract::Experiments were carried out to determine if the difference in rates of cell proliferation between normal and neoplastic cells may be related to altered levels of oxidative enzymes. Assays were performed using homogenates from hepatocellular carcinoma HC-252, a rapidly growing and moderately well-differentiated tumor;...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sun AS,Cederbaum AI

    更新日期:1980-12-01 00:00:00

  • Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.

    abstract::The standard systemic treatment for prostate cancer (PCa) is androgen ablation, which causes tumor regression by inhibiting activity of the androgen receptor (AR). Invariably, PCa recurs with a fatal androgen-refractory phenotype. Importantly, the growth of androgen-refractory PCa remains dependent on the AR through v...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0594

    authors: Dehm SM,Schmidt LJ,Heemers HV,Vessella RL,Tindall DJ

    更新日期:2008-07-01 00:00:00

  • Differentiation and the multiple drug resistance phenotype in human leukemic cells.

    abstract::A common feature of mammalian cell lines selected for multiple drug resistance is the overexpression of a high-molecular-weight surface membrane glycoprotein(s). While its amount has been shown to be related to the degree of resistance of such cells, its function in this phenomenon remains obscure. Because there are s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Beck WT,Cirtain MC,Ashmun RA,Mirro J

    更新日期:1986-09-01 00:00:00

  • CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.

    abstract::Antitumor type I T-cell responses involving IFN-γ production are critical to control cancer, but the efficacy of this response is limited by a variety of immunosuppressive mechanisms that promote tumoral immune escape. One critical mechanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-0579

    authors: Redjimi N,Raffin C,Raimbaud I,Pignon P,Matsuzaki J,Odunsi K,Valmori D,Ayyoub M

    更新日期:2012-09-01 00:00:00

  • Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells.

    abstract::2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine (Cl-F-ara-A) is a new deoxyadenosine analogue that is resistant to phosphorolytic cleavage and deamination. Studies with a variety of cell lines demonstrated that Cl-F-ara-A is a potent cytotoxic agent; in cell-free systems, its triphosphate (Cl-F-ara-ATP) i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Xie C,Plunkett W

    更新日期:1995-07-01 00:00:00

  • The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.

    abstract::Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potent inducer of apoptosis of transformed and cancer cells but not of most normal cells. Recent studies have revealed an unforeseen toxicity of TRAIL toward normal human hepatocytes, thereby bringing into question the safety of systemic administrati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ozoren N,Kim K,Burns TF,Dicker DT,Moscioni AD,El-Deiry WS

    更新日期:2000-11-15 00:00:00

  • An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.

    abstract::Cancer procoagulant (CP) is a Mr 68,000 cysteine proteinase that initiates blood coagulation and is expressed by a variety of malignant cells but not by normally differentiated cells. Polyclonal immunoglobulin G and monoclonal immunoglobulin M antibodies were developed to purified CP and used to develop an enzyme-link...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gordon SG,Cross BA

    更新日期:1990-10-01 00:00:00

  • Lymphoid cell subpopulations infiltrating into autologous rat tumors undergoing rejection.

    abstract::Lymphoid cell subpopulations infiltrating into autografts of methylcholanthrene-induced sarcomas in rats immunized with autologous tumor cells were identified in terms of immunohistochemical and cytofluorographic techniques using various monoclonal antibodies raised against different classes of rat lymphohemopoietic c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ishii Y,Matsuura A,Takami T,Uede T,Ibayashi Y,Uede T,Imamura M,Kikuchi K,Kikuchi Y

    更新日期:1984-09-01 00:00:00

  • Cancer suppression at old age.

    abstract::Increased age is regularly linked with heightened cancer risk, but recent research suggests a flattening around age 80. We report that, independent of cancer site or time period, most incidence rates decrease in the more elderly and drop to or toward zero near the ceiling of human life span. For all major organ sites,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1670

    authors: Harding C,Pompei F,Lee EE,Wilson R

    更新日期:2008-06-01 00:00:00

  • Alterations of the INK4a/ARF locus in human intracranial germ cell tumors.

    abstract::Little is known about the molecular mechanisms responsible for the development of intracranial germ cell tumors (ICGTs). Recently, we demonstrated that the balance of the p53-mdm2 interactions is disrupted in ICGTs. The p14ARF product, a tumor suppresser gene located on the INK4a/ARF locus, acts as one of the major fa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Iwato M,Tachibana O,Tohma Y,Arakawa Y,Nitta H,Hasegawa M,Yamashita J,Hayashi Y

    更新日期:2000-04-15 00:00:00

  • Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.

    abstract::alpha-Difluoromethylornithine (DFMO), an enzyme-activated irreversible inhibitor of ornithine decarboxylase (ODC), was used to select two very highly drug-resistant cell lines, designated K562-DFMOr and V79-DFMOr. Both DFMO-resistant cell lines exhibited elevated ODC expression due to gene amplification. Moreover, the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ask A,Persson L,Rehnholm A,Frostesjö L,Holm I,Heby O

    更新日期:1993-11-01 00:00:00

  • Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212.

    abstract::Monoclonal antibodies (MAbs) 123C3 and 123A8 generated against a membrane preparation of a small cell lung carcinoma (SCLC) specimen recognize not only SCLC and bronchial carcinoids but also a significant portion of non-small cell lung carcinomas (non-SCLC) of various histological types. Together with 13 other monoclo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Moolenaar CE,Muller EJ,Schol DJ,Figdor CG,Bock E,Bitter-Suermann D,Michalides RJ

    更新日期:1990-02-15 00:00:00

  • Activation of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in H35 hepatoma and Chinese hamster ovary cells by a phorbol ester tumor promoter.

    abstract::The ability of the phorbol ester tumor promoter 12-O-tetradecanoylphorbol- 13-acetate (TPA) to lead to the activation of cyclic adenosine 3':5'-monophosphate (cAMP)-dependent protein kinase was investigated in three cell lines. In the Reuber H35 hepatoma cells, TPA (1.6 microM) led to an increase in the protein kinase...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Byus CV,Trevillyan JM,Cavit LJ,Fletcher WH

    更新日期:1983-07-01 00:00:00

  • Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.

    abstract::We have evaluated immunohistochemical characteristics of tumors and the infiltrating cells in patients treated with various immunotherapy regimens. Forty-eight patients with advanced malignancies were treated with high dose i.v. recombinant interleukin-2 alone or in combination with cyclophosphamide, recombinant tumor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rubin JT,Elwood LJ,Rosenberg SA,Lotze MT

    更新日期:1989-12-15 00:00:00

  • Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.

    abstract::We studied the correlation between the formation of brain metastasis and the malignant growth potential of seven human melanoma cell lines, isolated from lymph node metastases (A375-SM, TXM-1, DM-4) or from brain metastases (TXM-13, TXM-18, TXM-34, TXM-40), and the potential of three variants of the mouse K-1735 melan...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhang RD,Price JE,Schackert G,Itoh K,Fidler IJ

    更新日期:1991-04-15 00:00:00

  • Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors.

    abstract::Driver tyrosine kinase mutations are rare in sarcomas, and patterns of tyrosine phosphorylation are poorly understood. To better understand the signaling pathways active in sarcoma, we examined global tyrosine phosphorylation in sarcoma cell lines and human tumor samples. Anti-phosphotyrosine antibodies were used to p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3015

    authors: Bai Y,Li J,Fang B,Edwards A,Zhang G,Bui M,Eschrich S,Altiok S,Koomen J,Haura EB

    更新日期:2012-05-15 00:00:00

  • The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.

    abstract::Compelling evidences indicate a key role for regulatory T cells (T(reg)) on the host response to cancer. The Wilms' tumor antigen (WT1) is overexpressed in several human leukemias and thus considered as promising target for development of leukemia vaccine. However, recent studies indicated that the generation of effec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0050

    authors: Lehe C,Ghebeh H,Al-Sulaiman A,Al Qudaihi G,Al-Hussein K,Almohareb F,Chaudhri N,Alsharif F,Al-Zahrani H,Tbakhi A,Aljurf M,Dermime S

    更新日期:2008-08-01 00:00:00

  • Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.

    abstract::Radiolabeled first-generation anti-tumor-associated glycoprotein-72 (TAG-72) monoclonal antibody (MAb), B72.3, has proven useful in detecting primary and secondary colorectal carcinoma. It has been anticipated that the development of second-generation, higher affinity, anti-TAG-72 MAbs, CC49 and CC83, would be of grea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gallinger S,Reilly RM,Kirsh JC,Odze RD,Schmocker BJ,Hay K,Polihronis J,Damani MT,Shpitz B,Stern HS

    更新日期:1993-01-15 00:00:00

  • Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.

    abstract::Recent reports have variously described expression of Fas ligand (FasL) or its absence in human tumors. The importance of the Fas-FasL mechanism for the immune evasion by tumors provided a strong rationale for the examination of FasL expression and function in squamous cell carcinoma of the head and neck (SCCHN), whic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gastman BR,Atarshi Y,Reichert TE,Saito T,Balkir L,Rabinowich H,Whiteside TL

    更新日期:1999-10-15 00:00:00

  • Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.

    abstract::Loss of expression of the apoptosis protease activator protein-1 (APAF-1) in human melanoma is thought to promote resistance to programmed cell death by preventing caspase-9 activation. However, the role of the APAF-1-dependent pathway in apoptosis activated by cellular stress and/or DNA damage has been recently quest...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1640

    authors: Zanon M,Piris A,Bersani I,Vegetti C,Molla A,Scarito A,Anichini A

    更新日期:2004-10-15 00:00:00

  • iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy.

    abstract::Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to radiotherapy, chemotherapy, or a combination of these modalities, and surgery remains the only curative intervention for localized disease. Although cancer-associated fibroblasts (CAF) are abundant in PDAC tumors, the effects of radiotherapy on CAFs and th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-2991

    authors: Pereira PMR,Edwards KJ,Mandleywala K,Carter LM,Escorcia FE,Campesato LF,Cornejo M,Abma L,Mohsen AA,Iacobuzio-Donahue CA,Merghoub T,Lewis JS

    更新日期:2020-04-15 00:00:00

  • Relationship of spontaneous regional lymph node metastases to dose of local irradiation of primary B16 melanomas.

    abstract::We evaluated the effects of local X-irradiation on microscopic or small macroscopic primary melanomas in the feet of C57BL/6 mice and the subsequent development of spontaneous femoral lymph node (LN) metastases. Doses of 30, 40, 55, 62.5, or 72.5 Gy often cured the foot tumor and metastases to regional femoral lymph n...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nathanson SD,Westrick P,Anaya P,Hetzel FW,Jacobsen G

    更新日期:1989-08-15 00:00:00

  • 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies.

    abstract::Earlier studies have shown guanine arabinoside (ara-G) is an effective agent against growth of T-cell lines and freshly isolated human T-leukemic cells. However, poor water solubility of ara-G limits clinical use. 2-Amino-6-methoxypurine arabinoside (506U) is a water-soluble prodrug converted to ara-G by adenosine dea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lambe CU,Averett DR,Paff MT,Reardon JE,Wilson JG,Krenitsky TA

    更新日期:1995-08-01 00:00:00

  • CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.

    abstract::Immunostimulatory CpG oligodeoxynucleotides (ODNs) can enhance the therapeutic effect of monoclonal antibodies (mAbs) by enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Distinct classes of CpG ODNs have been found recently to stimulate different effector cell populations. We used murine cancer models t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: van Ojik HH,Bevaart L,Dahle CE,Bakker A,Jansen MJ,van Vugt MJ,van de Winkel JG,Weiner GJ

    更新日期:2003-09-01 00:00:00